- /
- Supported exchanges
- / US
- / CLPBF.PINK
Coloplast A/S (CLPBF PINK) stock market data APIs
Coloplast A/S Financial Data Overview
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Coloplast A/S (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Coloplast A/S data using free add-ons & libraries
Get Coloplast A/S Fundamental Data
Coloplast A/S Fundamental data includes:
- Net Revenue: 27 891 M
- EBITDA: 8 584 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-02-06
- EPS/Forecast: 6.07
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Coloplast A/S News
New
Coloplast A/S - Updated Financial Calendar 2025-26
Coloplast A/S Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and th...
Coloplast A/S reports Q1 results
* Coloplast A/S press release [https://static.seekingalpha.com/uploads/sa_presentations/406/121406/original.pdf] (CLPBF [https://seekingalpha.com/symbol/CLPBF]): Q1 * Revenue of DKK7.04B (+0.1% Y/...
Coloplast AS (CLPBF) Q1 2026 Earnings Call Highlights: Strong Organic Growth Amid Market Challenges
This article first appeared on GuruFocus. Organic Revenue Growth: 6% in Q1 2025/26. EBIT Growth: 3% in constant currencies before special items. Return on Invested Capital: 15% after tax and before s...
Coloplast A/S - Interim Financial Report, Q1 2025/26
2025/26 Interim financial results, Q1 2025/26 1 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK gr...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.